EE200200717A - Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid - Google Patents
Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadidInfo
- Publication number
- EE200200717A EE200200717A EEP200200717A EEP200200717A EE200200717A EE 200200717 A EE200200717 A EE 200200717A EE P200200717 A EEP200200717 A EE P200200717A EE P200200717 A EEP200200717 A EE P200200717A EE 200200717 A EE200200717 A EE 200200717A
- Authority
- EE
- Estonia
- Prior art keywords
- depression
- treatment
- medicinal product
- piperazine derivatives
- anxiety neurosis
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000192856 | 2000-06-27 | ||
PCT/JP2001/005524 WO2002000259A1 (fr) | 2000-06-27 | 2001-06-27 | Agent therapeutique contre l'anxiete nevrotique ou la depression et derive de piperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200200717A true EE200200717A (et) | 2004-08-16 |
Family
ID=18691931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200717A EE200200717A (et) | 2000-06-27 | 2001-06-27 | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid |
Country Status (22)
Country | Link |
---|---|
US (1) | US6949552B2 (hu) |
EP (1) | EP1295608A4 (hu) |
JP (1) | JP5002881B2 (hu) |
KR (1) | KR20030013470A (hu) |
CN (1) | CN1438897A (hu) |
AU (2) | AU2001266342B2 (hu) |
BG (1) | BG107371A (hu) |
BR (1) | BR0111976A (hu) |
CA (1) | CA2413506A1 (hu) |
CZ (1) | CZ20024165A3 (hu) |
EA (2) | EA005737B1 (hu) |
EE (1) | EE200200717A (hu) |
HR (1) | HRP20030056A2 (hu) |
HU (1) | HUP0301719A2 (hu) |
IL (1) | IL153706A0 (hu) |
MX (1) | MXPA02012707A (hu) |
NO (1) | NO20026122L (hu) |
NZ (1) | NZ523800A (hu) |
PL (1) | PL360286A1 (hu) |
SK (1) | SK18322002A3 (hu) |
WO (1) | WO2002000259A1 (hu) |
ZA (1) | ZA200210386B (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE200200717A (et) | 2000-06-27 | 2004-08-16 | Taisho Pharmaceutical Co., Ltd. | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid |
US7456184B2 (en) | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
AU2002331064B2 (en) | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7732451B2 (en) | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
MXPA04005999A (es) * | 2001-12-21 | 2005-07-13 | Taisho Pharma Co Ltd | Derivado de piperazina. |
US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
US7968548B2 (en) * | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
US7419980B2 (en) * | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
US7491723B2 (en) * | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
EP1867641A4 (en) * | 2005-04-04 | 2010-01-13 | Takeda Pharmaceutical | A PROPHYLACTIC OR THERAPEUTIC MEDICINE AGAINST AQUEOUS DEPRESSION OR NEUROSIS |
US20070021433A1 (en) | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
WO2008039863A2 (en) * | 2006-09-27 | 2008-04-03 | Braincells, Inc. | Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
EP2072050A1 (en) | 2007-12-21 | 2009-06-24 | Santhera Pharmaceuticals (Schweiz) AG | Compounds with anti-emetic effect |
AR078340A1 (es) | 2009-09-07 | 2011-11-02 | Vifor Int Ag | Antagonistas de la etanodiamina-hepcidina |
US8609672B2 (en) | 2010-08-27 | 2013-12-17 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
US9018395B2 (en) | 2011-01-27 | 2015-04-28 | Université de Montréal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1317053A (fr) * | 1961-03-17 | 1963-02-01 | Soc Ind Fab Antibiotiques Sifa | Nouveaux dérivés de la pipérazine, et procédé de préparation |
CA918659A (en) * | 1969-07-31 | 1973-01-09 | Yoshitomi Pharmaceutical Industries | 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines |
FR2601364B1 (fr) * | 1986-07-09 | 1988-10-21 | Adir | Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
GB9021453D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
JPH0641071A (ja) * | 1991-09-06 | 1994-02-15 | Taisho Pharmaceut Co Ltd | インドール酢酸エステル誘導体 |
GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
SE9700620D0 (sv) * | 1997-02-21 | 1997-02-21 | Wapharm Ab | Cykliska peptider med selektivitet för MSH-receptor subtyper |
EP1085869A4 (en) * | 1998-06-11 | 2001-10-04 | Merck & Co Inc | SPIRO PIPERID DERIVATIVES AS MELANOCORTIN RECEPTORAGONISTS |
EE200200717A (et) | 2000-06-27 | 2004-08-16 | Taisho Pharmaceutical Co., Ltd. | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid |
-
2001
- 2001-06-27 EE EEP200200717A patent/EE200200717A/xx unknown
- 2001-06-27 EP EP01943844A patent/EP1295608A4/en not_active Withdrawn
- 2001-06-27 BR BR0111976-1A patent/BR0111976A/pt not_active IP Right Cessation
- 2001-06-27 IL IL15370601A patent/IL153706A0/xx unknown
- 2001-06-27 US US10/311,429 patent/US6949552B2/en not_active Expired - Fee Related
- 2001-06-27 CZ CZ20024165A patent/CZ20024165A3/cs unknown
- 2001-06-27 WO PCT/JP2001/005524 patent/WO2002000259A1/ja not_active Application Discontinuation
- 2001-06-27 CA CA002413506A patent/CA2413506A1/en not_active Abandoned
- 2001-06-27 AU AU2001266342A patent/AU2001266342B2/en not_active Ceased
- 2001-06-27 CN CN01811767A patent/CN1438897A/zh active Pending
- 2001-06-27 KR KR1020027017682A patent/KR20030013470A/ko not_active Application Discontinuation
- 2001-06-27 PL PL36028601A patent/PL360286A1/xx not_active Application Discontinuation
- 2001-06-27 SK SK1832-2002A patent/SK18322002A3/sk unknown
- 2001-06-27 JP JP2002505040A patent/JP5002881B2/ja not_active Expired - Fee Related
- 2001-06-27 EA EA200300071A patent/EA005737B1/ru not_active IP Right Cessation
- 2001-06-27 NZ NZ523800A patent/NZ523800A/en unknown
- 2001-06-27 AU AU6634201A patent/AU6634201A/xx not_active Withdrawn
- 2001-06-27 MX MXPA02012707A patent/MXPA02012707A/es unknown
- 2001-06-27 EA EA200500087A patent/EA200500087A1/ru unknown
- 2001-06-27 HU HU0301719A patent/HUP0301719A2/hu unknown
-
2002
- 2002-12-11 BG BG107371A patent/BG107371A/bg unknown
- 2002-12-19 NO NO20026122A patent/NO20026122L/no not_active Application Discontinuation
- 2002-12-20 ZA ZA200210386A patent/ZA200210386B/en unknown
-
2003
- 2003-01-27 HR HR20030056A patent/HRP20030056A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6634201A (en) | 2002-01-08 |
HUP0301719A2 (hu) | 2003-09-29 |
MXPA02012707A (es) | 2003-04-25 |
ZA200210386B (en) | 2004-02-10 |
AU2001266342B2 (en) | 2005-01-27 |
CA2413506A1 (en) | 2002-12-20 |
EP1295608A4 (en) | 2004-03-31 |
HRP20030056A2 (en) | 2005-02-28 |
CZ20024165A3 (cs) | 2004-03-17 |
KR20030013470A (ko) | 2003-02-14 |
NZ523800A (en) | 2005-02-25 |
CN1438897A (zh) | 2003-08-27 |
PL360286A1 (en) | 2004-09-06 |
NO20026122L (no) | 2003-02-25 |
US6949552B2 (en) | 2005-09-27 |
US20030186992A1 (en) | 2003-10-02 |
EA200500087A1 (ru) | 2005-06-30 |
EP1295608A1 (en) | 2003-03-26 |
IL153706A0 (en) | 2003-07-06 |
SK18322002A3 (sk) | 2003-09-11 |
JP5002881B2 (ja) | 2012-08-15 |
EA005737B1 (ru) | 2005-06-30 |
NO20026122D0 (no) | 2002-12-19 |
EA200300071A1 (ru) | 2003-06-26 |
WO2002000259A1 (fr) | 2002-01-03 |
BG107371A (bg) | 2003-08-29 |
BR0111976A (pt) | 2003-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200717A (et) | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid | |
DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
LTC1345910I2 (lt) | Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas | |
DE60121992D1 (de) | Zusammensetzung zur verabreichung und beschichtung medizinischer geräte | |
EE200200442A (et) | Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks | |
ATE318590T1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
HUP0302719A3 (en) | Substituted amine derivatives and their use for the treatment of angiogenesis | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
ATE344253T1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
DE60115418D1 (de) | Mikroinfusionsvorrichtung zur verabreichung von medikamenten | |
ATE438639T1 (de) | 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel | |
NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
PT1313489E (pt) | Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
EE200300167A (et) | Amidoalküülpiperidiini ja -piperasiini derivaadid, neid sisaldav farmatseutiline kompositsioon ningühendite kasutamine närvisüsteemi häirete raviks | |
EE200200271A (et) | Ravimkombinatsioonid ning nende kasutamine | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
NO20023448D0 (no) | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin | |
ATE431142T1 (de) | Arzneimittel zur behandlung und vermeidung neurogener schmerzen | |
HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
PL367676A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
ATE359285T1 (de) | Verwendung von scopinester derivaten zur herstellung von arzneimitteln | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
IS6172A (is) | Notkun melatoníns til lækninga |